第860回千葉医学会例会・第16回千葉大学放射線医学教室例会

Methylation pattern in tumours and normal tissues. The methylation signature of RASSF1Îą, TIMP3 and PCQAP in HNSCC and normal tissues from The Cancer Genome Atlas (TCGA) database. (DOCX 91 kb

Additional file 1: Figure S1. of Salivary DNA methylation panel to diagnose HPV-positive and HPV-negative head and neck cancers

MED15/PCQAP MSP amplicon sequence confirmation. The alignment of MED15/PCQAP MSP amplicon sequence in the NCBI Basic Local Alignment Search Tool (BLAST) database. (DOCX 218 kb

Additional file 3: Figure S2. of Salivary DNA methylation panel to diagnose HPV-positive and HPV-negative head and neck cancers

The amplification regions of individual genes with respective promoter start sites and CpG islands. A detailed map illustrating the location of the amplification region, promoter start site and CpG islands for RASSF1Îą, p16 INK4a , TIMP3 and PCQAP. (DOCX 260 kb

Additional file 2: Table S2. of A pilot study to compare the detection of HPV-16 biomarkers in salivary oral rinses with tumour p16INK4a expression in head and neck squamous cell carcinoma patients

Summary of results for the detection of HPV-16-specific DNA and RNA in oral rinse of patients with p16INK4a-positive HNSCC (XLSX 41 kb

Additional file 1: Supplementary Table S1. of A pilot study to compare the detection of HPV-16 biomarkers in salivary oral rinses with tumour p16INK4a expression in head and neck squamous cell carcinoma patients

Demographic characteristics, lifestyle and tumor characteristics of study participants (DOCX 18 kb

Additional file 3: Table S3. of A pilot study to compare the detection of HPV-16 biomarkers in salivary oral rinses with tumour p16INK4a expression in head and neck squamous cell carcinoma patients

Summary of results for the detection of HPV-16-specific DNA and RNA in oral rinse of patients with p16INK4a-negative HNSCC (XLSX 38 kb

Comparison of the NT-proBNP immunoassay when compared with a commercially available diagnostic assay (Roche Diagnostics, USA).

<p>r2 = 0.78 and p<0.001.</p

The comparison of the plasma and salivary NT-proBNP concentrations for HF patients (n = 45).

<p>(A), NT-proBNP levels in saliva of HF patients (n = 45) and healthy participants (n = 40). (B), The correlation of NT-proBNP concentrations in plasma and saliva of HF patients measured by our NT-proBNP immunoassay.</p

Characteristics of HF patients and healthy controls.

<p>Results are shown as median (min-max) for the data without normal distribution.</p><p>P_M = p-value for 2-tailed Mann-Whitney <i>U</i> test.</p><p>P_C = p-value for 2-sided Chi-square test.</p>*<p>Significant at 0.05 level.</p><p>n/a = Not applicable.</p

Performance characteristics of our NT-proBNP immunoassay.

<p>Performance characteristics of our NT-proBNP immunoassay.</p